This inventor holds 1 USPTO granted patent. Top assignee: Mogam Biotechnology Institute. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Innovative Contributions of Inventor Yungdae Yun in Immunology
Introduction
Yungdae Yun, a dedicated inventor based in Seoul, South Korea, has made significant strides in the field of immunology. With one patented invention to his name, he demonstrates a commitment to advancing medical science and understanding how to combat various immune-related challenges.
Latest Patents
Yungdae Yun holds a patent titled "Use of Rosmarinic Acid and Derivatives Thereof as an Immunosuppressant." This innovative invention focuses on utilizing rosmarinic acid and its derivatives as immunosuppressive agents and inhibitors of SH2 domain function. The patent reveals that rosmarinic acid can specifically inhibit the binding of ligand peptides to the Lck SH2 domain, disrupt Lck-mediated signal transduction in T cells, and suppress immune responses in transplanted tissues. The implications of this discovery are vast, potentially contributing to treatments for graft rejection, graft-versus-host disease (GVHD), autoimmune diseases, and inflammatory conditions.
Career Highlights
Yungdae Yun is affiliated with the Mogam Biotechnology Research Institute, where he actively engages in groundbreaking research. His work is a testament to his expertise in biochemistry and immunology, showcasing his ability to translate scientific discoveries into tangible applications that can improve health outcomes.
Collaborations
Throughout his career, Yungdae has collaborated with esteemed colleagues, including Eun Mi Hur and Young Bong Choi. These partnerships highlight the importance of teamwork in scientific innovation and advancing complex research projects aimed at addressing critical health issues.
Conclusion
Yungdae Yun's contributions to the field of immunology through his patented invention exemplify the potential of innovative research in medicine. His work at the Mogam Biotechnology Research Institute, paired with collaborative efforts, underscores the impact that a single inventor can have on developing applications that may significantly benefit individuals facing immune-related health challenges.